New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 7, 2013
08:30 EDTAGNAllergan price target raised to $118 from $104 at Argus
Argus increased its target on Allergan as the firm believes that the company reported solid sales and earnings growth ,and has a strong pipeline. The firm expects the company to generate double digit earnings growth over the next three to five years, driven by several positive catalysts. It maintains a Buy rating on the shares.
News For AGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for AGN

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use